All posts by: Michael Zand

Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy … – GlobeNewswire (press release)

PR Newswire (press release)Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy …GlobeNewswire (press release)CAMBRIDGE, Mass., April 30, 2018 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (… Continue reading

Immunotherapy Combinations Show Promise for Blood Cancers – Medscape

MedscapeImmunotherapy Combinations Show Promise for Blood CancersMedscapeClinical trials with immunotherapy combinations are expanding rapidly, and it is easy to envision profound antitumor effects. Unlike the incremental improvements in progression-fr… Continue reading

T cell biomarker predicts which CLL patients will respond to CAR T cell therapy – EurekAlert (press release)

EurekAlert (press release)

T cell biomarker predicts which CLL patients will respond to CAR T cell therapy EurekAlert (press release) PHILADELPHIA – Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don’t respond to chimeric antigen receptor (CAR) T cell therapy, and the answer is tied to how primed patients’ immune … and more »